APA

Brannagan T. H., Wang A. K., Coelho T., Waddington Cruz M., Polydefkis M. J., Dyck P. J., Plante-Bordeneuve V., Berk J. L., Barroso F., Merlini G., Conceição I., Hughes S. G., Kwoh J., Jung S. W., Guthrie S., Pollock M., Benson M. D. & Gertz M. (20210625). Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial. : European journal of neurology.

Chicago

Brannagan T H, Wang A K, Coelho T, Waddington Cruz M, Polydefkis M J, Dyck P J, Plante-Bordeneuve V, Berk J L, Barroso F, Merlini G, Conceição I, Hughes S G, Kwoh J, Jung S W, Guthrie S, Pollock M, Benson M D and Gertz M. 20210625. Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial. : European journal of neurology.

Harvard

Brannagan T. H., Wang A. K., Coelho T., Waddington Cruz M., Polydefkis M. J., Dyck P. J., Plante-Bordeneuve V., Berk J. L., Barroso F., Merlini G., Conceição I., Hughes S. G., Kwoh J., Jung S. W., Guthrie S., Pollock M., Benson M. D. and Gertz M. (20210625). Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial. : European journal of neurology.

MLA

Brannagan T H, Wang A K, Coelho T, Waddington Cruz M, Polydefkis M J, Dyck P J, Plante-Bordeneuve V, Berk J L, Barroso F, Merlini G, Conceição I, Hughes S G, Kwoh J, Jung S W, Guthrie S, Pollock M, Benson M D and Gertz M. Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial. : European journal of neurology. 20210625.